Synthon generics
Complex small-molecule generics and hybrids form the backbone of our product portfolio.
Synthon manufacturing
Our products are currently approved by regulatory agencies in about 100 countries worldwide and are marketed through strategic partnerships and – in dedicated areas – through direct sales.
Synthon pipeline generics
Synthon's generic pipeline is focused around complex molecules.
Synthon business development generics
We believe in a collaborative model, based upon strong partnerships with partner companies.
Synthon event calendar
Synthon will be present at the following events: